imatinib mesylate has been researched along with Abnormalities, Drug-Induced in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, R; Jain, A; Jain, N; Sharma, D | 1 |
| Broutin, S; Gil, S; Jovelet, C; Mir, O; Paci, A | 1 |
| Bláha, L; Isidori, M; Piscitelli, C; Russo, C; Smutná, M | 1 |
| Apperley, J | 2 |
3 review(s) available for imatinib mesylate and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
[Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?].
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Agents; Dasatinib; Erlotinib Hydrochloride; Female; Fetus; Gefitinib; Humans; Imatinib Mesylate; Lapatinib; Maternal Age; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk | 2016 |
Issues of imatinib and pregnancy outcome.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Benzamides; Drug-Related Side Effects and Adverse Reactions; Female; Fertility; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Protein-Tyrosine Kinases; Pyrimidines; Quality of Life; Risk Factors; Teratogens | 2009 |
CML in pregnancy and childhood.
Topics: Abnormalities, Drug-Induced; Adult; Age Factors; Benzamides; Child; Female; Fetal Diseases; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Maternal-Fetal Exchange; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pyrimidines; Treatment Outcome; Young Adult | 2009 |
2 other study(ies) available for imatinib mesylate and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
A newborn with teratogenic effect of imatinib mesylate: a very rare case report.
Topics: Abnormalities, Drug-Induced; Antineoplastic Agents; Female; Humans; Imatinib Mesylate; Infant, Low Birth Weight; Infant, Newborn; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pregnancy; Pregnancy Complications, Neoplastic | 2015 |
Teratogenic effects of five anticancer drugs on Xenopus laevis embryos.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Biological Assay; Capecitabine; Cisplatin; Embryo, Nonmammalian; Embryonic Development; Etoposide; Fluorouracil; Imatinib Mesylate; Teratogens; Toxicity Tests; Xenopus laevis | 2016 |